Company intelligence / Profile preview

Sysmex

Ownership: Public · 6869
Employees: ~10000
Development stage: Other

Overview

Sysmex’s products are widely used in clinical laboratories worldwide for routine and advanced diagnostics. The company leads the global market in hematology analyzers and has commercialized innovative platforms for cancer gene panel testing and rapid intraoperative detection of lymph node metastasis. Its technologies are validated through extensive global adoption in hospitals and labs

Therapeutic areas: NephrologyHematologyOncologyInfectious Diseases
Modalities: DeviceReagentSoftware
Industry: Molecular Diagnostics

Partnerships

Partec GmbH collaboration/acquisition for flow cytometry systemsJoint venture with Kawasaki Heavy Industries for medical robotics ("hinotori" surgical system)Collaborations with academic institutions on cancer genomics panels

Financials

Market cap: $7.9B
Total revenue: $3.2B
Enterprise value: $7.9B

Beyond the preview

Go deeper on Sysmex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sysmex.